The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study)

Diabetes, Obesity and Metabolism

Volumn 10, Issue 12, 2008, Pages 1239-1247

  Barnett, Anthony H ^a   Krentz, A J ^b   Strojek, K ^c   Sieradzki, J ^d   Azizi, F ^e   Embong, M ^f   Imamoglu, S ^g   Perusicova J ^h   Uliciansky V ⁱ   Winkler, G ^j  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d JAGIELLONIAN UNIVERSITY   (Poland)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f SCHOOL OF PHYSICS   (Malaysia)

^g ULUDAG UNIVERSITY   (Turkey)

^h CHARLES UNIVERSITY   (Czech Republic)

ⁱ University of Kosice   (Slovakia)

^j ST JOHN'S HOSPITAL   (Hungary)

more..

Author keywords

Gliclazide modified release; Glycaemic control; Self monitoring of blood glucose (SMBG); Type 2 diabetes

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE; GLICLAZIDE; HEMOGLOBIN A1C; INSULIN DERIVATIVE; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RELEASE; DRUG WITHDRAWAL; FEMALE; GLYCEMIC CONTROL; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; SELF MONITORING; SIDE EFFECT; SINGLE DRUG DOSE; SYMPTOM; WEIGHT REDUCTION;

EID: 55449121471     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2008.00894.x     Document Type: Article

References (38)

1. Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): A prospective observational study. BMJ 2000; 321: 405-412.
2. Liebl A, Mata M, Eschwege E. Evaluation of risk factors for development of complications in type II diabetes in Europe. Diabetologia 2002; 45: S23-S28.
3. Koro CE, Bowlin SJ, Bourgeois N et al. Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes. Diabetes Care 2004; 27: 17-20.
4. Fox KM, Gerber RA, Bolinder B, Chen J, Kumar S. Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom General Practice Research Database: A series of retrospective analyses of data from 1998 through 2002. Clin Ther 2006; 28: 388-395.
5. American Diabetes Association. Self-monitoring of blood glucose (Consensus Statement). Diabetes Care 1997; 19: 62-66.
6. American Diabetes Association. Clinical practice recommendations. Diabetes Care 2000; 23: S1-S116.
7. Diabetes Education Study Group (DESG) of the European Association for the Study of Diabetes. 1996. DESG teaching letter number 3: self-monitoring. Available from URL: http://www.desg.org. Accessed February 2008.
8. Charbonnel B, Boivineau C, Chopinet P et al. Blood glucose self-monitoring in diabetes. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases. Diabetes Metab 1995; 21: 285-289.
9. IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes. Brussels: International Diabetes Federation, 2005.
10. Faas A, Schellevis FG, Van Eijk JT. The efficacy of self-monitoring of blood glucose in NIDDM subjects: A criteria-based literature review. Diabetes Care 1997; 20: 1482-1486.
11. Gallichan M. Self monitoring of glucose by people with diabetes: evidence based practice. BMJ 1997; 314: 964-967.
12. Halimi S. Benefits of blood glucose self-monitoring in the management of insulin-dependent (IDDM) and non-insulin-dependent diabetes (NIDDM). Analysis of the literature: Mixed results. Diabetes Metab 1998; 24 (Suppl. 3): 35-41.
13. Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminathan R. Self-monitoring in type 2 diabetes mellitus: A meta-analysis. Diabet Med 2000; 17: 755-761.
14. Brown SA, Garcia AA, Kouzekanani K et al. Culturally competent diabetes self-management education for Mexican Americans: The Starr County border health initiative. Diabetes Care 2002; 25: 259-268.
15. Davidson MB, Castellanos M, Kain D et al. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: A blinded, randomized trial. Am J Med 2005; 118: 422-425.
16. Guerci B, Drouin P, Grange V et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: The Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003; 29: 587-594.
17. Kwon HS, Cho JH, Kim HS et al. Establishment of blood glucose monitoring system using the internet. Diabetes Care 2004; 27: 478-483.
18. Schwedes U, Siebolds M, Mertes G; SMBG Study Group. Meal-related structured self-monitoring of blood glucose: Effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 2002; 25: 1928-1932.
19. Karter AJ, Ackerson LM, Darbinian JA et al. Self-monitoring of blood glucose levels and glycemic control: The Northern California Kaiser Permanente Diabetes registry. Am J Med 2001; 111: 1-9.
20. Sarol JN, Nicodemus NA, Tan KM, Grava MB. Self-monitoring of blood glucose as a part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: A meta-analysis (1966-2004). Curr Med Res Opin 2005; 21: 173-182.
21. Welschen LM, Bloemendal E, Nijpels G et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: A systematic review. Diabetes Care 2005; 28: 1510-1517.
22. Jansen JP. Self-monitoring of glucose in type 2 diabetes mellitus: A Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin 2006; 22: 671-681.
23. Kennedy L. Self-monitoring of blood glucose in type 2 diabetes: Time for evidence of efficacy. Diabetes Care 2001; 24: 977-978.
24. Ipp E, Aquino RL, Christensen P. Point: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: The sanguine approach. Diabetes Care 2005; 28: 1528-1530.
25. Schernthaner G. Gliclazide modified release: A critical review of pharmacodynamic, metabolic, and vasoprotective effects. Metabolism 2003; 52: 29-34.
26. Schernthaner G, Grimaldi A, Di Mario U et al. GUIDE study: Double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest 2004; 34: 535-542.
27. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998; 21 (Suppl. 1): S5-S19.
28. Diabetes and Nutrition Study Group of the European Association for the Study of Diabetes. Nutritional recommendations for individuals with diabetes mellitus. Diabetes Nutr Metab 1988; 1: 145-149.
29. Harrower A. Gliclazide modified release: From once-daily formulation to 24-hour blood glucose control. Metabolism 2000; 49: 7-11.
30. Rutten G, Van Eijk J, De Nobel E, Beek M, Van der Velden H. Feasibility and effects of a diabetes type II protocol with blood glucose self-monitoring in general practice. Fam Pract 1990; 7: 273-278.
31. Farmer A, Wade A, Goyder E et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007; 335: 132-140.
32. Martin S, Schneider B, Heinemann L et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: An epidemiological cohort study. Diabetologia 2006; 49: 271-278.
33. Drouin P, Standl E, for the Diamicron MR Study Group. Gliclazide modified release: Results of a 2-year study in patients with type 2 diabetes. Diabetes Obes Metab 2004; 6: 414-421.
34. Lu CH, Chang CC, Chuang LM, Wang CY, Jiang YD, Wu HP. Double-blind, randomized, multicentre study of the efficacy and safety of gliclazide-modified release in the treatment of Chinese type 2 diabetic patients. Diabetes Obes Metab 2006; 8: 184-191.
35. Drouin P. Diamicron MR once daily is effective and well tolerated in type 2 diabetes: A double-blind, randomized, multinational study. J Diabetes Complications 2000; 14: 185-191.
36. Jonsson B; CODE-2 Advisory Board. Revealing the cost of type II diabetes in Europe. Diabetologia 2002; 45: S5-S12.
37. American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 2003; 26: 917-932.
38. Davidson MB. Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin. Diabetes Care 2005; 28: 1531-1533.